Therapeutic Potential of EVs: Targeting Cardiovascular Diseases

Therapeutic Potential of EVs: Targeting Cardiovascular Diseases

Due to their different biological functions, extracellular vesicles (EVs) have great potential from a therapeutic point of view. They are released by all cell types, carrying and delivering different kinds of biologically functional cargo. Under pathological events, cells can increase their secretio...

Full description

Bibliographic Details
Main Authors:	Javier Laura Francés, Christina Pagiatakis, Vittoria Di Mauro, Montserrat Climent
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Biomedicines
Subjects:	extracellular vesicles exosomes EVs cardiovascular diseases myocardial infarction diabetic cardiomyopathy
Online Access:	https://www.mdpi.com/2227-9059/11/7/1907

Similar Items

Extracellular vesicles: Targeting the heart
by: Xin Yin, et al.
Published: (2023-01-01)

Mechanisms and therapeutic strategies of extracellular vesicles in cardiovascular diseases
by: Qirong Li, et al.
Published: (2023-12-01)

EV Cargo Sorting in Therapeutic Development for Cardiovascular Disease
by: Cherrie D. Sherman, et al.
Published: (2021-06-01)

Extracellular Vesicle-Based Therapeutics for Heart Repair
by: Laura Saludas, et al.
Published: (2021-02-01)

Extracellular Vesicles in Therapeutics: A Comprehensive Review on Applications, Challenges, and Clinical Progress
by: Jiyoung Goo, et al.
Published: (2024-02-01)

Novel Applications of Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Therapeutics
by: Sho Joseph Ozaki Tan, et al.
Published: (2020-05-01)

Exosomes and Other Extracellular Vesicles with High Therapeutic Potential: Their Applications in Oncology, Neurology, and Dermatology
by: Urszula Szwedowicz, et al.
Published: (2022-02-01)

Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications
by: Shuang Zhao, et al.
Published: (2024-11-01)

Investigating the Potential and Pitfalls of EV-Encapsulated MicroRNAs as Circulating Biomarkers of Breast Cancer
by: Brian M. Moloney, et al.
Published: (2020-01-01)

Hypoxia and TNF‐alpha modulate extracellular vesicle release from human induced pluripotent stem cell‐derived cardiomyocytes
by: Margarida Viola, et al.
Published: (2024-11-01)

In situ‐crosslinked Zippersomes enhance cardiac repair by increasing accumulation and retention
by: Natalie E. Jasiewicz, et al.
Published: (2024-11-01)

Engineering extracellular vesicles for targeted therapeutics in cardiovascular disease
by: Enze Fu, et al.
Published: (2024-12-01)

Exosome in Cardiovascular Diseases: A Complex World Full of Hope
by: Gloria Bellin, et al.
Published: (2019-02-01)

Clinical signature of exosomal tetraspanin proteins in cancer
by: Asmit Das, et al.
Published: (2024-08-01)

Strategies for Application of Extracellular Vesicles in Solid Cancer Therapy
by: jamal majidpoor, et al.
Published: (2023-10-01)

Impact of the Main Cardiovascular Risk Factors on Plasma Extracellular Vesicles and Their Influence on the Heart’s Vulnerability to Ischemia-Reperfusion Injury
by: Miłosz Majka, et al.
Published: (2021-11-01)

Extracellular Vesicle (EV) Survivin for Cancer Diagnostics and Therapeutics: A Review
by: Wynne Wijaya, et al.
Published: (2024-08-01)

Extracellular vesicles and Duchenne muscular dystrophy pathology: Modulators of disease progression
by: Laura Yedigaryan, et al.
Published: (2023-02-01)

Editorial: Extracellular vesicle-derived non-coding RNAs (EV-ncRNAs) and their multifaceted roles in cancer biology
by: Nahid Neamati, et al.
Published: (2023-06-01)

Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display
by: Travis J. Antes, et al.
Published: (2018-08-01)

Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy
by: Yating Wu, et al.
Published: (2024-05-01)

Design and Evaluation of Engineered Extracellular Vesicle (EV)-Based Targeting for EGFR-Overexpressing Tumor Cells Using Monobody Display
by: Hiroaki Komuro, et al.
Published: (2022-01-01)

Reprogramming Extracellular Vesicles for Protein Therapeutics Delivery
by: Leyla A. Ovchinnikova, et al.
Published: (2021-05-01)

A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication
by: Ya-Juan Liu, et al.
Published: (2023-04-01)

Editorial: Role of extracellular vesicles (EVs) in pathogenesis, diagnosis, therapeutic delivery, treatment and theranostic applications in cancer
by: Reza Shahbazi, et al.
Published: (2023-09-01)

Similarities and Differences in Extracellular Vesicle Profiles between Ischaemic Stroke and Myocardial Infarction
by: Laura Otero-Ortega, et al.
Published: (2020-12-01)

Insight into Extracellular Vesicle-Cell Communication: From Cell Recognition to Intracellular Fate
by: Lana Ginini, et al.
Published: (2022-04-01)

Internalisation of RGD-Engineered Extracellular Vesicles by Glioblastoma Cells
by: Dovydas Gečys, et al.
Published: (2022-10-01)

Extracellular Vesicles in Chronic Demyelinating Diseases: Prospects in Treatment and Diagnosis of Autoimmune Neurological Disorders
by: Leyla A. Ovchinnikova, et al.
Published: (2022-11-01)

Plant-derived extracellular vesicles: a novel nanomedicine approach with advantages and challenges
by: Mohadeseh Nemati, et al.
Published: (2022-05-01)

EV-out or EV-in: Tackling cell-to-cell communication within the tumor microenvironment to enhance anti-tumor efficacy using extracellular vesicle-based therapeutic strategies
by: Wararat Chiangjong, et al.
Published: (2022-11-01)

Exosomes in Cardiovascular Diseases
by: Marta Zarà, et al.
Published: (2020-11-01)

EV‐ADD, a database for EV‐associated DNA in human liquid biopsy samples
by: Thupten Tsering, et al.
Published: (2022-10-01)

The human neurosecretome: extracellular vesicles and particles (EVPs) of the brain for intercellular communication, therapy, and liquid-biopsy applications
by: Taliah Soleymani, et al.
Published: (2023-05-01)

Biogenesis and delivery of extracellular vesicles: harnessing the power of EVs for diagnostics and therapeutics
by: Jivin Yu, et al.
Published: (2024-01-01)

Should Cell Culture Platforms move towards EV therapy requirements?
by: Ana eAiastui
Published: (2015-01-01)

Food‐derived extracellular vesicles in the human gastrointestinal tract: Opportunities for personalised nutrition and targeted therapeutics
by: Natalie P. Turner
Published: (2024-05-01)

Advancements in extracellular vesicle targeted therapies for rheumatoid arthritis: insights into cellular origins, current perspectives, and emerging challenges
by: Maryam Talebi Jouybari, et al.
Published: (2024-09-01)

Circulatory Astrocyte and Neuronal EVs as Potential Biomarkers of Neurological Dysfunction in HIV-Infected Subjects and Alcohol/Tobacco Users
by: Sunitha Kodidela, et al.
Published: (2020-05-01)

Exosomal miRNA‐21‐5p and miRNA‐21‐3p as key biomarkers of myocardial infarction
by: Reza Sahebi, et al.
Published: (2024-07-01)